Smith Chas P & Associates Pa Cpas / JNJ
Smith Chas P & Associates Pa Cpas’s Johnson & Johnson Position
Does Smith Chas P & Associates Pa Cpas own Johnson & Johnson (JNJ)? Yes — 251.9K shares worth $62M (+3.34% of its 13F portfolio) as of Q1 2026, down from 256.9K shares the prior filed quarter.
Position Value
$62M
Q1 2026
Shares
251.9K
% of Portfolio
+3.34%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 251.9K | $62M | +3.34% |
| Q4 2025 | 256.9K | $53M | +2.80% |
| Q3 2025 | 159.2K | $30M | +2.56% |
| Q2 2025 | 259.5K | $40M | +2.23% |
| Q1 2025 | 253.4K | $42M | +2.44% |
| Q4 2024 | 243.7K | $35M | +2.03% |
| Q3 2024 | 259.2K | $42M | +2.37% |
| Q2 2024 | 262.2K | $38M | +2.27% |
| Q1 2024 | 241.9K | $38M | +2.31% |
| Q4 2023 | 237.3K | $37,190 | +2.45% |
| Q3 2023 | 239.0K | $37,229 | +2.71% |
| Q2 2023 | 206.4K | $34,157 | +2.19% |
| Q1 2023 | 203.1K | $31,475 | +2.14% |
| Q4 2022 | 200.4K | $35,394 | +2.51% |
| Q3 2022 | 199.2K | $33M | +2.76% |
| Q2 2022 | 195.2K | $35M | +2.50% |
| Q1 2022 | 194.2K | $34M | +2.60% |
| Q4 2021 | 191.8K | $33M | +2.24% |
| Q3 2021 | 187.8K | $30M | +2.27% |
| Q2 2021 | 183.1K | $30M | +2.35% |
| Q1 2021 | 179.7K | $30M | +2.77% |
| Q4 2020 | 178.6K | $28M | +2.82% |
| Q3 2020 | 177.1K | $26M | +2.97% |
| Q2 2020 | 179.4K | $25M | +3.07% |
| Q1 2020 | 184.0K | $24M | +3.33% |
| Q4 2019 | 183.1K | $27M | +2.90% |
| Q3 2019 | 184.6K | $24M | +2.75% |
| Q2 2019 | 186.1K | $26M | +3.05% |
| Q1 2019 | 189.3K | $26M | +3.24% |
| Q4 2018 | 190.1K | $25M | +3.33% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Smith Chas P & Associates Pa Cpas’s full portfolio or all institutional holders of JNJ.